Oral and Poster Abstracts
Oral and Poster Abstracts
Oral and Poster Abstracts
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
2 University of Nottingham, Department of Veterinary Medicine,<br />
Nottingham, United Kingdom<br />
3 Orchard Veterinary Group, Glastonbury, United Kingdom<br />
4 Quality Milk Management Services Ltd., Wells, United Kingdom<br />
Objectives: The primary objective of the study was to determine the<br />
impact of the duration of treatment on the efficacy of penethamate<br />
hydriodide (Mamyzin ® Injection) in the cure of persistent bovine intramammary<br />
infection in U.K. dairy cows.<br />
Materials <strong>and</strong> Methods: Cows with a history of a high somatic cell count<br />
(SCC), four functional quarters, no significant teat lesions <strong>and</strong> in good<br />
general health were enrolled into a treatment study (n=95). Two different<br />
regimes were assessed using penethamate hydriodide, which was<br />
administered either as a four-day (“on-label”) course or a seven-day<br />
(“extended”) course. Intra-mammary infection status was monitored<br />
using both bacteriology <strong>and</strong> quarter somatic cell counting from 1-week<br />
pre-treatment until 4-weeks post-treatment. Multi-level statistical models<br />
were specified <strong>and</strong> interpreted within a Bayesian framework to estimate<br />
the probability of a difference between the two treatment groups<br />
(expressed as an odds ratio), using a flat, normal prior distribution.<br />
Results: Preliminary results have shown that both treatment groups<br />
experienced a significant reduction in the prevalence of gram-positive<br />
major pathogens from before until after treatment accompanied by a<br />
fall in somatic cell counts at both the quarter <strong>and</strong> cow level. There was<br />
a reduced odds of identifying a major pathogen after treatment in<br />
quarters treated for 7 days compared to quarters treated for 4 days<br />
(mean odds ratio = 0.57) <strong>and</strong> a posterior probability of 93% that<br />
treatment for 7 days resulted in fewer quarters with major pathogens<br />
than treatment for 4 days. There was an increased odds that quarters<br />
would remain below 200,000 cells/ml for 28 days after treatment for 7<br />
days compared to treatment for 4 days (odds ratio = 1.87) <strong>and</strong> a<br />
posterior probability of 79% that treatment for 7days resulted in fewer<br />
quarters > 200,000 cells/ml than treatment for 4 days.<br />
Conclusion: This study demonstrates the efficacy of Mamyzin ®<br />
Injection in the treatment of persistent IMI in dairy cows in the U.K.<br />
<strong>and</strong> has identified an increased probability of a cure when using a 7day,<br />
extended therapy regime, compared to 4-day, on-label treatment<br />
regime. In addition, the results can be used to inform clinical decisionmaking<br />
for the treatment of high SCC cows.<br />
Key words: somatic cell count, penethamate hydriodide, extended<br />
therapy, persistent infection, streptococcus uberis<br />
172 Challenge with Streptococcus uberis to Evaluate the Efficacy<br />
of Teat Sealers in Preventing Mastitis<br />
N. Williamson, K. Petrovski, C. Fern<strong>and</strong>ez<br />
Massey University, Institute of Veterinary, Animal <strong>and</strong> Biomedical<br />
Sciences, Palmerston North, New Zeal<strong>and</strong><br />
External teat sealers based on tetrahydrofuran (DryFlex (DF)) <strong>and</strong> a<br />
wound seal for humans 2-octylcyanoacrylate (B<strong>and</strong>-Aid (BA)) to prevent<br />
dry period mastitis were investigated. Streptococcus uberis has the<br />
highest incidence in the dry period <strong>and</strong> early lactation in New Zeal<strong>and</strong>. It<br />
is a ubiquitous environmental pathogen, is normally easy to cure using<br />
antibiotics <strong>and</strong> thus was an appropriate challenge organism. Quarter milk<br />
samples were taken for bacteriological culture from 175 cows, 4 <strong>and</strong> 1<br />
days before dry-off <strong>and</strong> twice within 4 days after calving. After the last<br />
milking, 88 cows received DF <strong>and</strong> 87 cows received BA. Pairs of contralateral<br />
quarters were r<strong>and</strong>omly assigned to the treated or the control group.<br />
All quarters were dipped in a Strep. uberis broth 2 <strong>and</strong> 4 days after dry-off<br />
<strong>and</strong> were assessed daily for clinical mastitis. Clinical mastitis iwas<br />
greatest 6-11 days after dry-off in both groups. Strep. uberis was the most<br />
prevalent bacterium isolated. In the DF group, 35 cases of clinical mastitis<br />
occurred in 176 treated quarters, compared with 83 in the 176 control<br />
quarters. In the BA group, 67 cases of clinical mastitis occurred in 174<br />
treated quarters, compared with 64 in 174 control quarters. DryFlex reduced<br />
mastitis after dry-off but not after calving. Octylcyanoacrylate did not<br />
reduce clinical mastitis after dry-off. A DryFlex type teat sealer showed<br />
potential in preventing mastitis in the early dry period, but has now been<br />
withdrawn worldwide. The effect of experimentally induced clinical<br />
mastitis in the early dry period on the subsequent lactation was examined.<br />
Cows (127) developing clinical mastitis after challenge were treated with<br />
antibiotic. Yields of milk, fat, protein <strong>and</strong> milk solids were analysed with<br />
respect to treatment group. No significant effect of treatment group on<br />
lactation yields of milk, fat, protein or milk solids occurred. No difference<br />
in production occurred (milk yield, 5126 vs. 5010 litres; fat yield, 267 vs.<br />
264 kg; protein yield, 182 vs. 179 kg) between cows that had mastitis <strong>and</strong><br />
52 XXV. Jubilee World Buiatrics Congress 2008<br />
those that did not. Promptly treated clinical mastitis due to Strep. uberis<br />
did not affect production in the subsequent lactation. The ability to<br />
demonstrate differences in efficacy <strong>and</strong> absence of production effects in<br />
the subsequent lactation mean this challenge model appears suitable for<br />
evaluating teat sealers.<br />
Key words: mastits, Streptococcus uberis, teat sealer<br />
173 Use of Leukocyte Differential Patterns to Optimize Diagnosis<br />
of Bovine Intramammary Infections: Evaluation of<br />
Partitioned vs. Non-partitioned Testing<br />
A. Rivas 1 , K. Anderson 1 , G. Leitner 2 , M. Chaffer 2 , O. Krifucks 2 ,<br />
R. Rodriguez 1<br />
1 North Carolina State University, College of Veterinary Medicine,<br />
Raleigh, NC, United States<br />
2 Kimron Veterinary Institute, Bacteriology,Beit-Dagan, Israel<br />
Objectives: To explore the use of leukocyte patterns in diagnosing<br />
infectious mastitis.<br />
Materials <strong>and</strong> methods: Quarter milk samples were investigated in 3<br />
cross-sectional studies conducted in the US (study I, n=120; <strong>and</strong> study<br />
III, n=500) <strong>and</strong> Israel (study II, n=484). The somatic cell count (SCC),<br />
milk microbiological cultures, <strong>and</strong> the percentages, total counts <strong>and</strong><br />
relative proportions of lymphocytes, macrophages <strong>and</strong> neutrophils<br />
were established. Non-periparturient (studies I <strong>and</strong> III) <strong>and</strong><br />
periparturient (study II) cows were assessed. Samples were collected<br />
without (studies I <strong>and</strong> III) <strong>and</strong> with previous determination of health<br />
status (study II). Disease prevalence was >40% (study I) <strong>and</strong>